Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Minerva Anestesiol ; 57(12 Suppl): 25-32, 1991 Dec.
Artículo en Italiano | MEDLINE | ID: mdl-1806830

RESUMEN

The Authors report on their experience about SvO2 continuous monitoring in order to find out the best therapeutic answer to inotropic drugs, knowing that, at constant values of SaO2 and Hb, possible variations of SvO2 reliably correspond with parallel variations of cardiac index (IC). Two groups of 15 patients each, suffering from low out-put syndrome, have been studied; patients have been treated with inotropic therapy based on Dobutamina and Amrinone. The 2 groups only differed from each other for the kind of monitoring: the first group was exposed to intermittent measurements of the cardiac out-put, while the second group was exposed to continuous monitoring of SvO2. Analysing the obtained results, the Authors notice not only a close correlation between the improvement of SvO2 and IC, but also a significant rediction in time required to dose drugs, owing to the constant help provided by on-line monitoring of SvO2. (table; see text)


Asunto(s)
Gasto Cardíaco Bajo/sangre , Oxígeno/sangre , Anciano , Amrinona/uso terapéutico , Gasto Cardíaco Bajo/tratamiento farmacológico , Dobutamina/uso terapéutico , Femenino , Humanos , Masculino , Oximetría , Síndrome , Venas
2.
Minerva Anestesiol ; 59(1-2): 19-22, 1993.
Artículo en Italiano | MEDLINE | ID: mdl-8474668

RESUMEN

The authors have studied the relationship between SvO2 and many parameters of oxygenation in MOSF patients specially in surviving patients and not surviving ones. They found that there is a close correlation between SvO2 and CI in the survivors indicates that, in these patients, we can increase cardiac activity to improve the cellular demand.


Asunto(s)
Insuficiencia Multiorgánica/sangre , Oximetría , Oxígeno/sangre , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Insuficiencia Multiorgánica/mortalidad , Estudios Retrospectivos
3.
Minerva Anestesiol ; 58(5): 311-4, 1992 May.
Artículo en Italiano | MEDLINE | ID: mdl-1635644

RESUMEN

A 42 year old man was admitted to the intensive Care Unit with signs and symptoms of septic shock, associated with adult respiratory distress syndrome (ARDS), jaundice and acute renal failure. In order to support different organs failures mechanical ventilation (IPPV, PSV, CPAP), continuous arteriovenous hemofiltration were affected, and continuous intravenous infusion of dopamine and dobutamine was started. After and during application of these therapeutic measures, continuous monitoring of mixed venous blood oxygen saturation (SvO2) was applied by Swan-Ganz fiber optic catheter in the pulmonary artery. Monitoring of SvO2 represented a useful means to guide inotropic therapy and to assess the hemodynamic effects of CAVH and mechanical ventilation. The case reported emphasized the role of continuous venous oximetry in multiple organ failure syndrome.


Asunto(s)
Hemofiltración , Insuficiencia Multiorgánica/terapia , Oxígeno/sangre , Adulto , Humanos , Masculino , Síndrome , Venas
4.
Minerva Anestesiol ; 58(5): 301-10, 1992 May.
Artículo en Italiano | MEDLINE | ID: mdl-1635643

RESUMEN

The authors describe the results obtained treating with amrinone for 48 hours 11 patients with acute heart failure. The patients (4 males and 7 females), age range between 50 and 82 years) received an initial bolus of 0.75 mg/kg followed by and infusion which on average was of 5.82 +/- 1.06 (SD) micrograms/kg/min. Besides a subjective and objective clinical improvement they could observe a quick and remarkable improvement of the main hemodynamic parameters (cardiac index, cardiac output, pulmonary capillary wedge pressure, mean pulmonary pressure). The tolerability of the drug was good, except for a decrease in platelet, already described in literature. In conclusion, the Authors consider amrinone a very interesting drug for its positive inotropic and vasodilating activity and because it does not cause an increase of the myocardial oxygen consumption.


Asunto(s)
Amrinona/uso terapéutico , Cuidados Críticos , Insuficiencia Cardíaca/tratamiento farmacológico , Enfermedad Aguda , Anciano , Anciano de 80 o más Años , Amrinona/farmacología , Enfermedad Crónica , Femenino , Insuficiencia Cardíaca/fisiopatología , Hemodinámica/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA